Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Study of Thrombin Generation During the 3 First Cycles of Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma

NCT01508416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Embolism and Thrombosis, +14 more
Locations
  • CHU de Clermont Ferrand Clermont-Ferrand, France
  • CHU de Nancy Nancy, France
  • Service de Médecine Interne - CHU de Saint Etienne Saint-Etienne, France
  • Service de rhumatologie - CHU de Saint Etienne Saint-Etienne, France
View Trial Details
Completed

Allo SCT in Amyloidosis Non-interventional Study

NCT02257905

Conditions
AL Amyloidosis, Amyloidosis, Immune System Diseases, +10 more
Locations
  • CHRU Limoges Limoges, France
  • University Hospital Eppendorf Hamburg, Germany
  • University of Heidelberg Heidelberg, Germany
  • University Hospital Basel, Switzerland
View Trial Details
Completed

Clinical Trial of PXD101 in Patients With Advanced Multiple Myeloma

NCT00131261

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • James Berenson, MD, Inc West Hollywood, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Chicago, Illinois, United States
  • Research Facility New York, United States
View Trial Details
Completed

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361

Conditions
Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia, +144 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
View all 23 locations
View Trial Details
Completed

A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib

NCT00689507

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • UCLA Los Angeles, California, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions